H2AJ and glioblastoma: In patients receiving combined treatment of radiation and TMZ followed by TMZ therapy only, H2AFJ upregulation significantly (p < 0.01) predicted a poor overall survival rate in patients with MGMT-unmethylated GBM (Figure 3G).